Literature DB >> 31235277

[Newborn screening for metabolic disorders in Spain and worldwide].

Daisy Emilia Castiñeras1, María-Luz Couce2, José Luis Marin3, Domingo González-Lamuño4, Hugo Rocha5.   

Abstract

Newborn screening programs are key players in a country's public health strategies, preventing the burden of care associated with the screened disorders. Its importance has dramatically intensified in recent years due to the increasing number of disorders that fulfil criteria for screening. Since the 1960's, many countries implemented newborn screening programs that are now, at least in developed countries, universal, well established, and with excellent results. Nevertheless, much work is still to be done, mainly in developing countries of Africa, Asia, and South America. In some European countries, including Spain, uniformity of screening panels between different regions is still a challenge, being a source of health inequalities between citizens. The authors will present the current status of newborn screening programs in Spain and integrate it into the current European and world scenario.
Copyright © 2019 Asociación Española de Pediatría. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cribado neonatal; Enfermedades metabólicas; España; Metabolic disorders; Newborn screening; Spain

Mesh:

Year:  2019        PMID: 31235277     DOI: 10.1016/j.anpedi.2019.05.007

Source DB:  PubMed          Journal:  An Pediatr (Engl Ed)        ISSN: 2341-2879


  6 in total

1.  Actualities in neonatal endocrine and metabolic screening.

Authors:  V Dima
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

2.  Inborn error of metabolism precipitated by COVID-19: challenges in the absence of an expanded newborn screening as state health programmes.

Authors:  Priyanka Olety; Gundyadka Moideen Safwan; Rathika Damodara Shenoy
Journal:  BMJ Case Rep       Date:  2022-06-07

3.  Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.

Authors:  Álvaro Martín-Rivada; Laura Palomino Pérez; Pedro Ruiz-Sala; Rosa Navarrete; Ana Cambra Conejero; Pilar Quijada Fraile; Ana Moráis López; Amaya Belanger-Quintana; Elena Martín-Hernández; Marcello Bellusci; Elvira Cañedo Villaroya; Silvia Chumillas Calzada; María Teresa García Silva; Ana Bergua Martínez; Sinziana Stanescu; Mercedes Martínez-Pardo Casanova; Miguel L F Ruano; Magdalena Ugarte; Belén Pérez; Consuelo Pedrón-Giner
Journal:  JIMD Rep       Date:  2022-01-27

4.  A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes.

Authors:  Alberto Burlina; Simon A Jones; Anupam Chakrapani; Heather J Church; Simon Heales; Teresa H Y Wu; Georgina Morton; Patricia Roberts; Erica F Sluys; David Cheillan
Journal:  Int J Neonatal Screen       Date:  2022-03-25

5.  Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe.

Authors:  Simon A Jones; David Cheillan; Anupam Chakrapani; Heather J Church; Simon Heales; Teresa H Y Wu; Georgina Morton; Patricia Roberts; Erica F Sluys; Alberto Burlina
Journal:  Int J Neonatal Screen       Date:  2022-03-15

6.  Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges.

Authors:  Safwan Dababneh; Mohammed Alsbou; Nashat Taani; Ghazi Sharkas; Refqi Ismael; Latifeh Maraqa; Omar Nemri; Hanin Al-Jawaldeh; Nadeen Kopti; Enas Atieh; Arab Almasri
Journal:  Children (Basel)       Date:  2022-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.